Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03472794
Other study ID # CHUBX 2016/19
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 16, 2018
Est. completion date June 17, 2019

Study information

Verified date September 2019
Source University Hospital, Bordeaux
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The project is imbued with the whole problematic of patient follow-up and patient support, taking into account the experiences and needs of breast cancer patients. It concerns the dissemination of knowledge through the implementation of a specific clinical innovation designed to optimizing breast cancer patient pathway. The " Patients en réseau " association offers us to participate at the web platform evolution Mon Réseau Cancer du Sein in adapting it. The feasibility study focuses on (1) the platform utilization and (2) sources and obstacles to its utilization in the French context


Description:

One of the French Cancer Plan 2014-2019 objectives is to improve the town-hospital coordination and information's exchange between professionals. This research project aims to reach this important objective of exchange development and the amelioration of the coordination concerning breast cancer women. Breast cancer requires the integration of aggressive treatments implying physical, psychological and social consequences. That's why an optimized care pathway needs a coordinated and multidisciplinary organization, and more particularly a personalized approach taking into account the whole patients' needs in physical, psychological and social perspectives. To reach this goal, it is important to support those patients, to answer their needs for a better disease management in their own health pathways. The research issues lie in this outcome.

The project is imbued with the whole problematic of patient follow-up and patient support, taking into account the experiences and needs of breast cancer patients. It concerns the dissemination of knowledge through the implementation of a specific clinical innovation designed to optimizing breast cancer patient pathway.

The " Patients en réseau " association offers us to participate at the web platform evolution Mon Réseau Cancer du Sein in adapting it. The feasibility study focuses on (1) the platform utilization and (2) sources and obstacles to its utilization in the French context


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date June 17, 2019
Est. primary completion date June 17, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria of patients :

- Age = 18 y.o;

- With a diagnosis of breast cancer,

- treated at the Bergonié Institute;

- Patients who express a non-opposition to participate to SAVAQ research;

- Patients who have an Internet access at home.

Inclusion criteria of healers :

- Doctors, Nurse, Senior health manager, Technologist medical imaging from the center participated to the research

Exclusion criteria of patients:

- Patients with a severe psychiatric pathology (medical diagnosis);

- Patients who doesn't speak French

Study Design


Related Conditions & MeSH terms


Intervention

Other:
web portal: " Mon réseau cancer du sein " ("My Breast cancer Network")
web portal: " Mon réseau cancer du sein "

Locations

Country Name City State
France Institut Bergonié Bordeaux

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Bordeaux SRIOP 2016, SIRIC BRIO

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasability of the web portal Number of connections to the portal each month:
Types of documents consulted
Types of downloaded documents
Types of documents sought
Connection duration
Number of connections
Number of comments / questions posted
Number of comments / questions viewed
Number of comments / questions sought
Month 6
Secondary Number of the portal connections realized each month Number of the portal connections realized each month Month 6
Secondary Number of webpages used Number of webpages used Month 6
Secondary Number of status posted Number of status posted Month 6
Secondary Number of comments/questions posted Number of comments/questions posted Month 6
Secondary Number of "like" emoticon posted Number of "like" emoticon posted Month 6
Secondary Number of "comfort" emoticon posted Number of "comfort" emoticon posted Month 6
Secondary Number of "favorites" emoticon posted Number of "favorites" emoticon posted Month 6
Secondary Number of "mood" posted Number of "mood" posted Month 6
Secondary Number of private posts posted Number of private posts posted Month 6
Secondary Number of webpages consulted Number of webpages consulted Month 6
Secondary Number of leaflets consulted Number of leaflets consulted Month 6
Secondary Headings of leaflets consulted Headings of leaflets consulted Month 6
Secondary Number of cards consulted Number of cards consulted Month 6
Secondary Headings of cards consulted Headings of cards consulted Month 6
Secondary Number of videos consulted Number of videos consulted Month 6
Secondary Headings of videos consulted Headings of videos consulted Month 6
Secondary Number of address consulted in the address list Number of address consulted in the address list Month 6
Secondary Number of upcoming events consulted Number of upcoming events consulted Month 6
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A